Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

atai Impact Fellowship Fund

Data updated

atai-funded fellowship program in psychedelic neuroscience supporting trainee and early-career researchers.

Foundations & Philanthropy Snapshot

Grant-Making Organizations

Classification

Grant Program (Host Organization)

Geography

National

Coverage

Coverage not set

Last Verified

Apr 10, 2026

Funding Focus Areas

Academic Research FundingTraining & Workforce Development

Support Types

Fellowship FundingGrant Funding

Philanthropy Notes

The fellowship fund is a dedicated program under atai Impact with public grant/fellowship announcements tied to MGH.

Verification

Verified

Psychedelic Focus

Explicit Psychedelic Focus

Engagement Status

Active

Primary Funding Link

Recorded Funding Activities

Massachusetts General Hospital Center for the Neuroscience of Psychedelics

Dec 1, 2021

Fellowship Funding - Launch of fellowship fund in psychedelic neuroscience - $2m fellowship fund

atai Impact establishes fellowship fund

Massachusetts General Hospital

Nov 15, 2022

Fellowship Funding - First fellowship cohort announced

atai Fellowship Fund first cohort announcement

Massachusetts General Hospital, Center for the Neuroscience of Psychedelics

Dec 16, 2021

fellowship - Establishment of the atai Fellowship Fund in Psychedelic Neuroscience - $2,000,000 (over a five-year program)

$2M, five-year fellowship fund supporting graduate students at MGH's Center for the Neuroscience of Psychedelics with access to neuroimaging, cognitive neuroscience and clinical-trial-design resources.

atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with MGH's Center for the Neuroscience of Psychedelics

Massachusetts General Hospital, Center for the Neuroscience of Psychedelics

Dec 16, 2022

fellowship - First cohort of the atai Fellowship Fund in Psychedelic Neuroscience (5 graduate fellows) - undisclosed (funded from the $2M fellowship fund)

First cohort of five graduate fellows, with projects spanning DMT chemical biology, ethnopharmacology of Central/South American psychedelic plants, systems-neuroscience modeling, epidemiology of psychedelics for suicidality, and psilocybin-assisted therapy for IBS.

The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort at Massachusetts General Hospital

Quick Facts

Website
Visit